JACOBS LEVY EQUITY MANAGEMENT, INC - TARSUS PHARMACEUTICALS INC ownership

TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 77 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of TARSUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$752,923
-49.4%
41,667
-52.1%
0.00%
-66.7%
Q3 2022$1,489,000
+24.3%
86,948
+6.0%
0.01%
+33.3%
Q2 2022$1,198,00082,0420.01%
Other shareholders
TARSUS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,140,586$38,038,2135.37%
Vivo Capital, LLC 2,262,200$40,199,2944.40%
TCG Crossover Management, LLC 1,142,857$20,308,5692.99%
Cormorant Asset Management, LP 2,621,422$46,582,6692.72%
Ghost Tree Capital, LLC 400,000$7,108,0002.34%
COWEN AND COMPANY, LLC 1,796,773$31,928,6562.23%
Frazier Life Sciences Management, L.P. 1,787,527$31,764,3552.11%
TFG Asset Management GP Ltd 615,000$10,928,5501.99%
Sands Capital Ventures, LLC 260,000$4,620,2001.37%
Ikarian Capital, LLC 518,519$9,214,0831.11%
View complete list of TARSUS PHARMACEUTICALS INC shareholders